-
1 Comment
DaVita Inc is currently in a long term uptrend where the price is trading 9.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
DaVita Inc's total revenue rose by 0.2% to $3B since the same quarter in the previous year.
Its net income has dropped by 29.0% to $174M since the same quarter in the previous year.
Finally, its free cash flow fell by 43.6% to $260M since the same quarter in the previous year.
Based on the above factors, DaVita Inc gets an overall score of 3/5.
Industry | Medical Care Facilities |
---|---|
Exchange | NYSE |
CurrencyCode | USD |
ISIN | US23918K1088 |
Sector | Healthcare |
Beta | 1.04 |
---|---|
Market Cap | 11B |
PE Ratio | 13.01 |
Target Price | 164.5678 |
Dividend Yield | None |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for DVA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025